latent tuberculosis infection - Globe Thesis

Keyword [latent tuberculosis infection] Result: 21 - 40 \| Page: 2 of 3
21.	Research On Screening Serum Biomarkers Using Mycobacterium Tuberculosis Proteome Microarray
22.	Risk And Management For Tuberculosis Infection In Patients With Inflammatory Bowel Disease Receiving Anti-tumor Necrosis Factor Treatment
23.	Latent Tuberculosis Infection In Patients With Inflammatory Bowel Disease Treated With Anti-TNF?:A Meta-analysis
24.	The Value Of T-SPOT.TB For Screening Tuberculosis Infection In Patients With Rheumatic Autoimmune Disease
25.	Research On Expression Of GBP5 And KLF2 Genes In Latent Tuberculosis Infection
26.	The Tuberculosis Risk Of Anti-TNF-? Treatment In Inflammatory Bowel Disease And The Screening Of Latent Tuberculosis Infection Before Anti-TNF-? Therapy
27.	Risk Analysis On Activation Of Latent Tuberculosis Infection In Patients With Rheumatic Diseases And Effect Of Prophylactic Therapy On Tuberculosis
28.	The Study On The Prevalence Of Latent Tuberculosis Infection And Risk Of Active Pulmonary Tuberculosis Among Coal Workers' Pneumoconiosis
29.	Research On Function Of TRIM Protein Family In Tuberculosis And Screening Diagostic Biomarkers For Tuberculosis
30.	Diagnostic Value Of Cytokines And Long Non-coding RNAs In Different Infection Status Of Mycobacterium Tuberculosis
31.	DUSP3,ASAP1,GBP5 Genes In Tuberculosis Patients And TB Latent Infection In The Crowd Expression Studies
32.	Study On The Immune Response And Related Mechanism Induced By DosR Antigen Rv2029c Of Mycobacterium Tuberculosis
33.	Clinical Application Of Blood Cell VCS Parameters In Diagnosis Of Active Pulmonary Tuberculosis
34.	Risk Factors On Tuberculosis Infection In Systemic Lupus Erythematosus Patients
35.	Clinical Application Of Mycobacterium Tuberculosis Rv1860,Rv0494 And Rv1876 Proteins In The Diagnosis Of Active Tuberculosis
36.	Change And Clinical Significance Of Serum IL-34 In Patients With Active Pulmonary Tuberculosis
37.	Clinical Significances Of The Lymphocyte Activation Markers And Cytokines In Differentiating Active And Latent Tuberculosis Infection With Healthy People
38.	Cost-effectiveness Of Preventive Treatment In Close Contacts Of Pulmonary Tuberculosis(PTB)Cases
39.	Acceptability Of Preventive Treatment Among Close Contacts Of Pulmonary Tuberculosis
40.	Treatment of latent tuberculosis infection with isoniazid (INH) for nine months versus rifampin and pyrazinamide (RZ) for two months: A comparison of rate of liver injury in Baltimore City Chest Clinic during 1999--2001
<<First <Prev Next> Last>> Jump to